ea0016p393 | Neuroendocrinology | ECE2008
Trento Marina
, Tibaldi Paola
, Balbo Marcella
, Kucich Claudia
, Basile Margherita
, Borgo Enrica
, Tomelini Michela
, Passera Pietro
, Giordano Roberta
, Arvat Emanuela
, Cavallo Franco
, Porta Massimo
Background and aims: Alterations of mood and depression may be associated with type 2 diabetes (T2DM) and impaired glucose metabolism in non-diabetic people. Central serotoninergic activity may modulate glucose tolerance via neuroendocrine effectors. The serotoninergic tone was assessed by measuring the hormonal response to a selective serotonin reuptake inhibitor, citalopram, in non-diabetic subjects and patients with T2DM followed by either a traditional approach or a clinic...